Skip to main navigation Skip to search Skip to main content

Epigenome-wide association study of human frontal cortex identifies differential methylation in Lewy body pathology

  • Lasse Pihlstrøm*
  • , Gemma Shireby
  • , Hanneke Geut
  • , Sandra Pilar Henriksen
  • , Annemieke J M Rozemuller
  • , Jon-Anders Tunold
  • , Eilis Hannon
  • , Paul Francis
  • , Alan J Thomas
  • , Seth Love
  • , Jonathan Mill
  • , Wilma D J van de Berg
  • , Mathias Toft
  • *Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

28 Citations (Scopus)
53 Downloads (Pure)

Abstract

Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are closely related progressive disorders with no available disease-modifying therapy, neuropathologically characterized by intraneuronal aggregates of misfolded α-synuclein. To explore the role of DNA methylation changes in PD and DLB pathogenesis, we performed an epigenome-wide association study (EWAS) of 322 postmortem frontal cortex samples and replicated results in an independent set of 200 donors. We report novel differentially methylated replicating loci associated with Braak Lewy body stage near TMCC2, SFMBT2, AKAP6 and PHYHIP. Differentially methylated probes were independent of known PD genetic risk alleles. Meta-analysis provided suggestive evidence for a differentially methylated locus within the chromosomal region affected by the PD-associated 22q11.2 deletion. Our findings elucidate novel disease pathways in PD and DLB and generate hypotheses for future molecular studies of Lewy body pathology.

Original languageEnglish
Article number4932
Number of pages10
JournalNature Communications
Volume13
Issue number1
DOIs
Publication statusPublished - 22 Aug 2022

Bibliographical note

Funding Information:
The study was funded by the Norwegian Health Association (grant 4799, L.P.) and the Research Council of Norway (grant 250597, M.T.). L.P. and M.T. also received additional funding from the South-Eastern Regional Health Authority, Norway, the Norwegian Parkinson Research Fund and Reberg’s Legacy. W.D.J.v.d.B. received funding from the Dutch Parkinson association, Health Holland, and Rotary Club Aalsmeer-Uithoorn. The authors are grateful to the Netherlands Brain Bank and its funders for providing the samples that made the study possible. The Brains for Dementia Research cohort, including the generation of DNA methylation data, is jointly funded by the UK Alzheimer’s Society and Alzheimer’s Research UK.

Funding Information:
The study was funded by the Norwegian Health Association (grant 4799, L.P.) and the Research Council of Norway (grant 250597, M.T.). L.P. and M.T. also received additional funding from the South-Eastern Regional Health Authority, Norway, the Norwegian Parkinson Research Fund and Reberg’s Legacy. W.D.J.v.d.B. received funding from the Dutch Parkinson association, Health Holland, and Rotary Club Aalsmeer-Uithoorn. The authors are grateful to the Netherlands Brain Bank and its funders for providing the samples that made the study possible. The Brains for Dementia Research cohort, including the generation of DNA methylation data, is jointly funded by the UK Alzheimer’s Society and Alzheimer’s Research UK.

Publisher Copyright:
© 2022, The Author(s).

Research Groups and Themes

  • Cerebrovascular and Dementia Research Group

Keywords

  • Epigenome
  • Frontal Lobe/pathology
  • Humans
  • Lewy Bodies/metabolism
  • Lewy Body Disease/genetics
  • Methylation
  • Parkinson Disease/genetics
  • alpha-Synuclein/genetics

Fingerprint

Dive into the research topics of 'Epigenome-wide association study of human frontal cortex identifies differential methylation in Lewy body pathology'. Together they form a unique fingerprint.

Cite this